Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) EPS (Basic): 2018-2024

Historic EPS (Basic) for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to -$0.15.

  • Eton Pharmaceuticals' EPS (Basic) fell 450.00% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.26, marking a year-over-year decrease of 18.18%. This contributed to the annual value of -$0.15 for FY2024, which is 275.00% down from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' EPS (Basic) is -$0.15, which was down 275.00% from -$0.04 recorded in FY2023.
  • Eton Pharmaceuticals' 5-year EPS (Basic) high stood at -$0.04 for FY2023, and its period low was -$1.33 during FY2020.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.15 (2024), whereas its average is -$0.18.
  • In the last 5 years, Eton Pharmaceuticals' EPS (Basic) spiked by 93.98% in 2021 and then crashed by 350.00% in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' EPS (Basic) (Yearly) stood at -$1.33 in 2020, then surged by 93.98% to -$0.08 in 2021, then plummeted by 350.00% to -$0.36 in 2022, then soared by 88.89% to -$0.04 in 2023, then slumped by 275.00% to -$0.15 in 2024.